It was at $4 when it missed its primary endpoint and people still kept buying it.
Classic case of PR being stronger than the product.Huge lose for Wilsons unless they have successfully traded it like many .Orbis have 14% and are still adding.omg.
Same thing about to happen to another spin driven Bio I know off imo.
Regards,